Cite
HARVARD Citation
Straus, D. et al. (2020). Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Leukemia & lymphoma. 61 (12), pp. 2931-2938. [Online].